Zydus, supported by Gates Foundation, to develop combination vaccine against shigellosis and typhoid
This combination of vaccines, if found successful, will safeguard children against two lethal enteric diseases of global…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
India
EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth
The report titled ‘Viksit Bharat@2047: Transforming India from pharmacy of the world to pharma powerhouse for the world’ states…
19th International Conference of Drug Regulatory Authorities commences in India
ICDRA is being hosted for the first time in India, bringing together regulatory authorities, policymakers, and health officials…
Govt bans 156 FDCs with immediate effect
The notification by the Central Government stated “the said Expert Committee considered this FDC as irrational”
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
Navigating the IPR maze: India’s pharmaceutical challenge
Dr Deevanshu Shrivastava, Associate Dean, GD Goenka University, elaborates on the crucial role of IPR in India pharma Inc’s…
Revolutionising cancer treatment: The promise of point-of-care CAR-T therapy
Dr Prudwidhar S, Country Medical Affairs Director, Miltenyi Biotec emphasises why successful implementation of CAR-T cell therapy…
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0
Anil Matai, Director General, OPPI shares an optimistic outlook for further enhancements in quality healthcare through continued…
Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari
Exports are being made, particularly to the EU, UAE, and Japan, while other markets like Malaysia, Southeast Asia, and Taiwan are…
Greening India’s industrial horizon: Navigating climate resilience in pharma and beyond
Hisham Mundol, Chief Advisor, Environmental Defense Fund, India
Indian pharma industry in 21st century – What has changed for domestic supply?
Dr Ashok Omray, Pharma Consultant, points out that despite significant advancements, the Indian pharma industry grapples with…
Regulatory measures for cybersecurity in India’s pharmaceutical industry
By Sidharrth Shankar, Partner, JSA Advocates and Solicitors
DoP orders pharma cos to comply to self-declaration under UPCMP 2024
Executive heads of companies must sign and submit the declarations by June 30
iBRIC organises 2nd THSTI advanced course in vaccinology
This course aims to provide a comprehensive overview of the concepts and steps involved in the design, development and…
Drug shortage in the US to prove beneficial for Indian pharma companies
US-focused pharma companies to sustain their revenue improvement trend in FY25 on account of heightened drug shortages in the US…
Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India
Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India…